Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10165)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2018 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang K, Baldwin GS, Nikfarjam M, He H. p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation. World J Gastroenterol 2018; 24(33): 3709-3723 [PMID: 30197477 DOI: 10.3748/wjg.v24.i33.3709] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i33/3709.htm |
| Number | Citing Articles |
| 1 |
Keita Yamada, Kiyoshi Higashi, Hirohisa Nagahori, Koichi Saito. Circulating natural antibodies against 3’-sialyllactose complement the diagnostic performance of CA19-9 for the early detection of pancreatic ductal adenocarcinoma. Cancer Biomarkers 2019; 27(1): 121 doi: 10.3233/CBM-190158
|
| 2 |
Charudatt Samant, Ramesh Kale, Anand Bokare, Mahip Verma, K. Sreedhara Ranganath Pai, Mandar Bhonde. PAK4 inhibition significantly potentiates Gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAPK and p-AKT/PI3K pathways. Biochemistry and Biophysics Reports 2023; 35: 101544 doi: 10.1016/j.bbrep.2023.101544
|
| 3 |
Ying Zhou, Jian Zhang, Jian Wang, Mao‐Sheng Cheng, Dong‐Mei Zhao, Feng Li. Targeting PAK1 with the Small Molecule Drug AK963/40708899 Suppresses Gastric Cancer Cell Proliferation and Invasion by Downregulation of PAK1 Activity and PAK1‐Related Signaling Pathways. The Anatomical Record 2019; 302(9): 1571 doi: 10.1002/ar.24095
|
| 4 |
Baoyu Li, Bin Liu, Xianglian Zhang, Hui Liu, Lijie He. KIF18B promotes the proliferation of pancreatic ductal adenocarcinoma via activating the expression of CDCA8. Journal of Cellular Physiology 2020; 235(5): 4227 doi: 10.1002/jcp.29201
|
| 5 |
Weikang Kong, Lingxia Zhu, Tian Li, Jiao Chen, Bo Fan, Wenjing Ji, Chunli Zhang, Xueting Cai, Chunping Hu, Xiaoyan Sun, Peng Cao. Azeliragon inhibits PAK1 and enhances the therapeutic efficacy of AKT inhibitors in pancreatic cancer. European Journal of Pharmacology 2023; 948: 175703 doi: 10.1016/j.ejphar.2023.175703
|
| 6 |
Arian Ansardamavandi, Mehrdad Nikfarjam, Hong He. PAK in Pancreatic Cancer-Associated Vasculature: Implications for Therapeutic Response. Cells 2023; 12(23): 2692 doi: 10.3390/cells12232692
|
| 7 |
Hong He, Chelsea Dumesny, Ching-Seng Ang, Li Dong, Yi Ma, Jun Zeng, Mehrdad Nikfarjam. A novel PAK4 inhibitor suppresses pancreatic cancer growth and enhances the inhibitory effect of gemcitabine. Translational Oncology 2022; 16: 101329 doi: 10.1016/j.tranon.2021.101329
|
| 8 |
Chen Lu, Wei Jiang, Bingqing Hui, Dawei Rong, Kai Fu, Chaoxi Dong, Weiwei Tang, Hongyong Cao. The circ_0021977/miR‐10b‐5p/P21 and P53 regulatory axis suppresses proliferation, migration, and invasion in colorectal cancer. Journal of Cellular Physiology 2020; 235(3): 2273 doi: 10.1002/jcp.29135
|
| 9 |
Dongdong Wang, Ji Zhu, Yuanqing Yang, Zhizhou Wang, Zhengran Ying, Hailong Zhang. The role of the miR-4306/PAK6 axis in degenerative nucleus pulposus cells in human intervertebral disc degeneration. Cellular Signalling 2023; 102: 110528 doi: 10.1016/j.cellsig.2022.110528
|
| 10 |
Wenting Wang, Zhijian Xu, Ning Wang, Ruyong Yao, Tao Qin, Hao Lin, Lu Yue. Prognostic value of eight immune gene signatures in pancreatic cancer patients. BMC Medical Genomics 2021; 14(1) doi: 10.1186/s12920-020-00868-w
|
| 11 |
Young-Lan Park, Sang-Yoon Ha, Sun-Young Park, Jung-Ho Choi, Min-Woo Jung, Dae-Seong Myung, Hyun-Soo Kim, Young-Eun Joo. Reversine induces cell cycle arrest and apoptosis via upregulation of the Fas and DR5 signaling pathways in human colorectal cancer cells. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4746
|
| 12 |
Jian-Bo Shao, Xiang-Qian Luo, Li-Hua Mo, Gui Yang, Zhi-Qiang Liu, Jiang-Qi Liu, Zhi-Gang Liu, Da-Bo Liu, Ping-Chang Yang. Twist1 sustains the apoptosis resistance in eosinophils in nasal mucosa of allergic rhinitis. Archives of Biochemistry and Biophysics 2021; 702: 108828 doi: 10.1016/j.abb.2021.108828
|
| 13 |
Nikolaos Symeonidis, Maria Lambropoulou, Efstathios Pavlidis, Constantinos Anagnostopoulos, Alexandra Tsaroucha, Athanasia Kotini, Christina Nikolaidou, Anastasia Kiziridou, Constantinos Simopoulos. PAK1 Expression in Pancreatic Cancer: Clinicopathological Characteristics and Prognostic Significance. Clinical Medicine Insights: Oncology 2019; 13 doi: 10.1177/1179554919831990
|
| 14 |
Qin Yang, Yingchao Zhao, Yeshan Chen, Yu Chang, Ai Huang, Tie Xu, Guiling Li, Gang Wu. PAK6 promotes cervical cancer progression through activation of the Wnt/β‑catenin signaling pathway. Oncology Letters 2020; 20(3): 2387 doi: 10.3892/ol.2020.11797
|
| 15 |
Yi Ma, Mehrdad Nikfarjam, Hong He. The trilogy of P21 activated kinase, autophagy and immune evasion in pancreatic ductal adenocarcinoma. Cancer Letters 2022; 548: 215868 doi: 10.1016/j.canlet.2022.215868
|
| 16 |
Mingzhe Li, Jiaxin Zhou, Zhengkui Zhang, Jisong Li, Feng Wang, Ling Ma, Xiaodong Tian, Zebin Mao, Yinmo Yang. Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1. Chinese Medical Journal 2022; 135(19): 2326 doi: 10.1097/CM9.0000000000002154
|
| 17 |
Kinjal Shah, Julhash U. Kazi. Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.858782
|
| 18 |
Xiaodong Li, Feng Li. p21-Activated Kinase: Role in Gastrointestinal Cancer and Beyond. Cancers 2022; 14(19): 4736 doi: 10.3390/cancers14194736
|
| 19 |
Kai Wang, Yifan Zhan, Nhi Huynh, Chelsea Dumesny, Xiao Wang, Khashayer Asadi, David Herrmann, Paul Timpson, Yang Yang, Katrina Walsh, Graham S. Baldwin, Mehrdad Nikfarjam, Hong He. Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1. Cancer Letters 2020; 472: 8 doi: 10.1016/j.canlet.2019.12.020
|
| 20 |
Kai Wang, Hong He. Tumor Microenvironments in Organs. Advances in Experimental Medicine and Biology 2020; 1296: 243 doi: 10.1007/978-3-030-59038-3_15
|
| 21 |
Wei Mu, Zhe Wang, Margot Zöller. Ping-Pong—Tumor and Host in Pancreatic Cancer Progression. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01359
|
| 22 |
Lizhou Xu, Farid N. Faruqu, Yau M. Lim, Kee Y. Lim, Revadee Liam-Or, Adam A. Walters, Paul Lavender, David Fear, Claire M. Wells, Julie Tzu-Wen Wang, Khuloud T. Al-Jamal. Exosome-mediated RNAi of PAK4 prolongs survival of pancreatic cancer mouse model after loco-regional treatment. Biomaterials 2021; 264: 120369 doi: 10.1016/j.biomaterials.2020.120369
|
| 23 |
Kai Wang, Lili Yan, Xun Qiu, Huan Chen, Fengqiang Gao, Wenwen Ge, Zhengxing Lian, Xuyong Wei, Shuai Wang, Hong He, Xiao Xu. PAK1 inhibition increases TRIM21-induced PD-L1 degradation and enhances responses to anti-PD-1 therapy in pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(6): 167236 doi: 10.1016/j.bbadis.2024.167236
|
| 24 |
Stefania Belli, Ada Pesapane, Alberto Servetto, Daniela Esposito, Fabiana Napolitano, Claudia Maria Ascione, Alessandra Allotta, Nicola Zambrano, Federica Zito Marino, Renato Franco, Teresa Troiani, Luigi Formisano, Roberto Bianco. Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer. British Journal of Cancer 2023; 129(7): 1071 doi: 10.1038/s41416-023-02390-z
|
| 25 |
Hsing-Yu Wu, Ming-Chen Yang, Li-Yun Ding, Ching S. Chen, Po-Chen Chu. p21-Activated kinase 3 promotes cancer stem cell phenotypes through activating the Akt-GSK3β-β-catenin signaling pathway in pancreatic cancer cells. Cancer Letters 2019; 456: 13 doi: 10.1016/j.canlet.2019.04.026
|
| 26 |
Fangfang Zhuo, Shuang Luo, Wei He, Zhanhui Feng, Ya’nan Hu, Jingxia Xu, Zejun Wang, Jianwei Xu. The Role of Signaling Pathways in Pancreatic Cancer Targeted Therapy. American Journal of Clinical Oncology 2023; 46(3): 121 doi: 10.1097/COC.0000000000000979
|
| 27 |
Mohamed El-Tanani, Hamdi Nsairat, Ismail I. Matalka, Alaa A. A. Aljabali, Vijay Mishra, Yachana Mishra, Gowhar A. Naikoo, Sai Raghuveer Chava, Nitin B. Charbe, Murtaza M. Tambuwala. Impact of exosome therapy on pancreatic cancer and its progression. Medical Oncology 2023; 40(8) doi: 10.1007/s12032-023-02101-x
|